Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen
{{output}}
Background: Prostate cancer affects 1 in 6 men, and it is the second‑leading cause of cancer-related death in American men. Surgery is one of the main treatment modalities for prostate cancer, but it often results in incomplete ... ...
